For more information on this topic, please refer to the Point / Counterpoint and Practice articles in the January 2008 issue of Clinical Pharmacology & Therapeutics.

1. Is emergency contraception as effective in preventing pregnancy as studies suggest?

2. What, if any, are the social implications of increased accessibility to levonorgestrel?

3. How does the inability to precisely calculate efficacy affect the overall acceptability of emergency contraception?

4. Does evidence exist supporting cost-saving claims associated with emergency contraception?

5. What other issues related to efficacy, accessibility, and social expectations are important to consider when discussing emergency contraception?